№ files_lp_3_process_7_082403
File format: docx
Character count: 73431
File size: 138 KB
This document outlines the PBS restrictions for type 2 diabetes mellitus (T2DM) medicines, specifically focusing on SGLT2 inhibitors, DPP4 inhibitors, and GLP-1 RAs, providing recommendations for their updated use and potential budget impacts.
Year:
2023
Region / city:
Australia
Subject:
Type 2 diabetes mellitus treatment, PBS restrictions
Document type:
Policy/Regulatory recommendation
Authority:
PBAC (Pharmaceutical Benefits Advisory Committee)
Target audience:
Healthcare professionals, prescribers, pharmacists, pharmaceutical sponsors
Period of validity:
Ongoing
Approval date:
June 2023
Last modification date:
February 2023
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Not specified
Subject:
Type-2 Diabetes Mellitus (T2DM)
Document Type:
Research Table
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, healthcare professionals
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Context:
Comparative analysis of baseline characteristics between two groups of T2DM patients (attenders and non-attenders) based on various health indicators.
Year:
2026
Region / City:
India, West Bengal, Kolkata, Durgapur, Bhubaneswar
Subject:
Type 2 Diabetes Mellitus, Molecular Pathology, Diagnostics, Therapeutics
Document Type:
Research Article
Institution / Organization:
Apollo Multispecialty Hospital, IQ City Medical College, JIMSH, KIT
Authors:
Debatosh Datta, Sayan Howlader, Samannita Roy, Anubrata Chakraborty
Target Audience:
Medical researchers, clinicians, endocrinologists
Keywords:
T2DM, Diabetes Mellitus diagnostics, Diabetes Mellitus new therapy, Diabetic ischemic marker
Methodology:
Clinical assessment, Hemoglobin Glycation (HBA1c), Molecular analysis, Blood Glucose monitoring
Focus:
Molecular basis of T2DM-induced vasculitis, predictive diagnostics, fixed-phase glycation
Therapeutic Approaches Discussed:
Insulin therapy, oral hypoglycemics, pH modulation for aldehyde suppression
Status:
Unpublished ongoing experimental work on pH intervention in early and established T2DM cases
Year:
2024
Region / City:
Canberra, Australia
Topic:
Paediatric Diabetes Care
Document Type:
Clinical Guideline
Organization:
Canberra Health Services, Paediatric Endocrinology & Diabetes Service (PEDS)
Target Audience:
Paediatric endocrinologists, medical officers, ward nursing staff, diabetes educators
Age Group:
Children and adolescents 0–16 years
Scope:
Inpatient management of newly diagnosed Type 1 Diabetes Mellitus
Exclusions:
Diabetic Ketoacidosis management, Type 2 Diabetes, Cystic Fibrosis Related Diabetes, pre-existing T1DM, outpatient management
Year:
2023
Region / City:
Canberra
Topic:
Diabetes management, exercise therapy
Document Type:
Procedure
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Clinicians, healthcare professionals
Period of Validity:
Indefinite
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United Kingdom
Topic:
Healthcare, Diabetes Management
Document Type:
Business Rules
Organization / Institution:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES), NHS England
Target Audience:
Healthcare Professionals, NHS Staff
Period of Validity:
2023-2024
Approval Date:
12/04/2023
Date of Changes:
12/04/2023
Version:
48.249.0
Contents:
Business rules for quality outcomes in diabetes care as part of the QOF
Contextual description:
A technical document outlining the business rules and specifications for diabetes management under the Quality and Outcomes Framework for the UK National Health Service.
Year:
2022
Region / City:
Kangra, Himachal Pradesh
Subject:
Health
Document Type:
Call for Quotations
Organization / Institution:
Dr. Rajendra Prasad Government Medical College
Author:
Dr. Rashmi Kaul, Prof & Head of Dept. of Pathology
Target Audience:
Contractors, Individuals/Agencies for Research Project
Duration:
12 months
Approval Date:
19/3/2022
Amendment Date:
19/4/2022
Contextual Description:
A call for quotations for outsourcing a field investigator-cum-laboratory technician for a research project on anemia in diabetic patients at Dr. Rajendra Prasad Government Medical College.
Year:
2023
Region / City:
N/A
Subject:
Medical Education, Digital Learning
Document Type:
Instructional Guide
Institution:
N/A
Author:
N/A
Target Audience:
Faculty members, Medical Educators
Validity Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Description:
Instructional guide for medical faculty to create a digital teaching module focused on Early Clinical Exposure in Diabetes Mellitus using digital resources and online tools.
Note:
Year
Document type:
Interview guide
Research design:
Qualitative study
Data collection method:
Semi-structured interviews
Target population:
Women with history of GDM and their spouses
Health condition:
Gestational Diabetes Mellitus (GDM)
Related condition:
Type 2 Diabetes Mellitus (T2DM)
Institution:
National University of Singapore (NUS)
Topic areas:
Pregnancy experience, postpartum health, lifestyle changes, healthcare interactions, risk perception, technology-based interventions
Intervention focus:
App-based and wearable-supported lifestyle modification
Reporting framework referenced:
Standards for Reporting Qualitative Research (SRQR)
Source of reporting standards:
EQUATOR Network
Sections included:
Interview guide for women; Interview guide for spouses; Reporting standards checklist
Year:
2022
Region / City:
Not specified
Topic:
Post-traumatic osteoarthritis, diabetes, osteoarthritis models
Document Type:
Journal Articles
Organization / Institution:
Various medical research institutions
Authors:
Rios-Arce ND, Murugesh DK, Hum NR, Sebastian A, Jbeily EH, Christiansen BA, Loots GG, Christiansen BA, Chan DD, van der Meulen MCH, Maerz T, Hsia AW, Jbeily EH, Mendez ME, Cunningham HC, Biris KK, Bang H, Lee CA, Loots GG
Target Audience:
Medical professionals, researchers in osteoarthritis and diabetes
Period of validity:
2021-2022
Approval Date:
Not specified
Date of revisions:
Not specified
Year:
2026
Region / City:
Baghdad, Iraq
Topic:
Type 2 Diabetes Mellitus, Periodontal Disease, Fungal Infections, Obesity, Inflammation
Document Type:
Research Article
Institution:
Gilgamesh University, College of Health and Medical Techniques
Authors:
Mohammed Mohaibes, Ammar Sabar, Mayada Al-khafaji
Target Audience:
Medical researchers, clinicians, and healthcare professionals
Study Design:
Case-control study
Sample Size:
150 participants (75 T2DM patients, 75 healthy controls)
Methods:
Oral swabs, blood analysis for CRP and ESR, fungal isolation via microscopy, culture, VITEK® 2 system
Period:
Not explicitly stated
Publication Status:
Preprint / Manuscript
Keywords:
Type 2 Diabetes Mellitus, Periodontal disease, Fungal infection, Obesity, Inflammation, CRP, ESR
Correspondence:
[email protected]
Year:
Not specified
Region / City:
Not specified
Topic:
Frailty, Diabetes Mellitus
Document Type:
Search strategy
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, medical professionals
Validity period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2025
Region / City:
Arlington, VA
Document Type:
Press Release
Organization:
PBS KIDS
Author:
Genie Deez, Thy Than
Target Audience:
Parents, Preschoolers
Period of Validity:
Fall 2025
Approval Date:
January 22, 2025
Funding Source:
Corporation for Public Broadcasting, U.S. Department of Education
Year:
2025
Region / City:
Cincinnati, OH
Subject:
Documentary
Document Type:
Film
Organization:
PBS
Author:
Yemi Oyediran
Target Audience:
General Public
Effective Date:
October 10, 2025
Date of Approval:
September 18, 2025
Description:
A documentary film about the history and cultural impact of King Records, shedding light on its groundbreaking role in American music.
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
Not specified
Region / City:
Not specified
Theme:
Reproduction, Biology
Document Type:
Worksheet
Author:
Not specified
Target Audience:
Students
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
Not specified
Year:
2000
Region / city:
United States
Theme:
Elections, History, Government
Document type:
Educational Lesson Plan
Author:
Stephanie Schragger
Target audience:
Students, Grades 7-12
Period of validity:
Not specified
Approval date:
Not specified
Date of last modification:
Not specified
Context:
Educational resource aimed at teaching about contested elections in U.S. history, specifically the 2000 and 2020 elections.
Year:
2025
Region / City:
New York City
Topic:
Documentary, Politics, History, Vietnam War
Document Type:
Documentary Film
Organization:
PBS, American Experience
Author:
Marc Levin, Daphne Pinkerson
Target Audience:
General Public, History and Politics Enthusiasts
Period of Action:
May 8, 1970
Approval Date:
N/A
Date of Changes:
N/A
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical benefits, chemotherapy, PBS
Document Type:
FAQ
Organization:
Pharmaceutical Benefits Scheme
Author:
Pharmaceutical Benefits Advisory Committee (PBAC)
Target Audience:
Healthcare providers, prescribers, patients
Effective Period:
From December 1, 2024
Approval Date:
Not specified
Modification Date:
Not specified
Contextual Description:
FAQ document providing detailed information on the changes in PBS listing for Opdualag and Vyxeos under the EFC Program, including prescription and claiming details.
Year:
2024
Region / city:
Australia
Topic:
Biosimilars, pharmaceutical regulation
Document type:
Submission report
Organ / institution:
Australian Government, Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Sandoz Pty Ltd
Target audience:
Regulatory bodies, pharmaceutical industry professionals
Period of validity:
2024–2025
Approval date:
15 May 2024
Date of changes:
March 2024